Source BioScience PLC Total Voting Rights (7956A)
September 30 2015 - 10:37AM
UK Regulatory
TIDMSBS
RNS Number : 7956A
Source BioScience PLC
30 September 2015
30 September 2015
Source BioScience plc
('Source BioScience' or 'the Company')
Total Voting Rights
In accordance with the FCA's Disclosure and Transparency Rules,
Source BioScience confirms that as at 30 September 2015 the Company
has 349,100,255 ordinary shares of 2 pence each in issue with no
ordinary shares held in treasury.
The figure of 349,100,255 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or change to their
interest in, Source BioScience plc under the FCA's Disclosure and
Transparency Rules. The voting rights of all ordinary shares in the
Company rank pari passu and the Company does not hold any ordinary
shares in treasury.
--- ENDS ---
Enquiries
Source BioScience plc
Dr Nick Ash, CEO
Tel: +44 (0) 115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
About Source BioScience
Source BioScience plc (LSE: SBS) is a trusted provider of state
of the art laboratory services and products to the healthcare and
clinical, life and applied sciences and biopharma industries. It is
an international business operating ten state of the art facilities
in five countries and with customers in over 90 countries
worldwide. The Group offers a complementary portfolio of laboratory
services and products that share common technologies, laboratory
processes, infrastructure and expertise. These include clinical
diagnostics, genomics, proteomics, drug discovery and development
research as well as controlled environment storage and testing
services for a diverse range of markets. These services and
products are provided to a large and diverse customer base
including the top 50 pharmaceutical companies, leading universities
and research institutes worldwide, the UK NHS and other healthcare
providers. The Group is listed on the Premium Main Market of the
London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRBSGDCLXXBGUG
(END) Dow Jones Newswires
September 30, 2015 10:37 ET (14:37 GMT)
Medical Solutions (LSE:MLS)
Historical Stock Chart
From May 2024 to Jun 2024
Medical Solutions (LSE:MLS)
Historical Stock Chart
From Jun 2023 to Jun 2024